Image Robyn Broad PhD, Senior Scientist, Tumour Profiling, Translational Sciences, Adaptimmune Limited, UK Robyn Broad completed her undergraduate degree in Biochemistry at the University of Manchester, UK in 2014. During her undergraduate degree, she had the opportunity of undertaking a placement year, which she completed at MedImmune, Cambridge UK. During her time at MedImmune, Robyn worked in both the phage display team and histology group, producing, and identifying IHC compatible antibodies for targets where commercial antibodies were not currently available. Following completion of her undergraduate degree, Robyn received her MSc in Cancer Research and Molecular Biomedicine again from the University of Manchester and received her PhD from the School of Medicine at the University of Leeds in 2019, where she investigated the role of cancer-associated fibroblasts on chemoresistance in triple negative breast cancer. Since 2018, Robyn has worked at Adaptimmune (Abingdon, UK), firstly within the Target Validation team identifying new targets to add to the Adaptimmune pipeline. Having cross trained within the Translational team during her time in Target Validation, Robyn moved over to the Tumor profiling team with Translational Sciences in January 2020. As part of the tumor profiling team, Robyn is responsible for analyzing tumor biopsies from Adaptimmune’s clinical trials, and detecting and quantifying the presence of Adaptimmune's SPEAR T-cells. In addition to this, the team is also tasked with understanding the tumor microenvironment within tumor biopsies. This is done through the use of multiplex staining and imaging technologies with spatial immunophenotyping alongside genomics and transcriptomics profiling. Published Pieces by Robyn Broad Characterizing the Tumor Microenvironment through Immunophenotyping and Spatial Biology using Ultivue 8-plex Immunofluorescence Technology on the BOND RX Research StainerウェビナーIn this webinar, learn more about how Adaptimmune uses custom-designed Ultivue 8-plex kits on the BOND RX research stainer system to enable the definition of the T cell phenotypes spatially and quantitively. Characterizing the Tumor Microenvironment through Immunophenotyping and Spatial Biology using Ultivue 8-plex Immunofluorescence Technology on the BOND RX Research StainerウェビナーIn this webinar, learn more about how Adaptimmune uses custom-designed Ultivue 8-plex kits on the BOND RX research stainer system to enable the definition of the T cell phenotypes spatially and quantitively.